Evaluation of synthetic peptides of WbSXP-1 for the diagnosis of human lymphatic filariasis

Diagnostic Microbiology and Infectious Disease

Volumn 68, Issue 4, 2010, Pages 410-415

  Pandiaraja, Pandurangan ^a   Arunkumar, Chakkaravarthy ^a   Hoti, Subhash Laxmanappa ^b   Rao, Donthamsetty Nageswara ^c   Kaliraj, Perumal ^a  

^a ANNA UNIVERSITY   (India)

^b VECTOR CONTROL RESEARCH CENTRE   (India)

^c ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Chimeric peptides; Diagnosis; Filariasis; SXP 1; Synthetic peptides; Wuchereria bancrofti

Indexed keywords

EPITOPE; PARASITE ANTIBODY; SYNTHETIC PEPTIDE;

ANTIBODY DETECTION; ARTICLE; B LYMPHOCYTE; CONTROLLED STUDY; CROSS REACTION; DIAGNOSTIC VALUE; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; IMMUNOREACTIVITY; LYMPHATIC FILARIASIS; MAJOR CLINICAL STUDY; NUCLEOTIDE SEQUENCE; PEPTIDE SYNTHESIS; PRIORITY JOURNAL; WUCHERERIA BANCROFTI;

AMINO ACID SEQUENCE; ANIMALS; ANTIBODIES, HELMINTH; ANTIGENS, HELMINTH; ELEPHANTIASIS, FILARIAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; IMMUNODOMINANT EPITOPES; MOLECULAR SEQUENCE DATA; PEPTIDES; RECOMBINANT PROTEINS; WUCHERERIA BANCROFTI;

EID: 78649274508     PISSN: 07328893     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diagmicrobio.2010.07.015     Document Type: Article

References (27)

1. Baskar L.K., Srikanth T.R., Suba S., Mody H.C., Desai P.K., Kaliraj P. Development and evaluation of a rapid flow-through immunofiltration test using recombinant filarial antigen for diagnosis of brugian and bancroftian filariasis. Microbiol. Immunol. 2004, 48:519.
2. Bruckdorfer T., Marder O., Albericio F. From production of peptides in milligram amounts for research to multi-tons quantities for drugs of the future. Curr. Pharm. Biotechnol. 2004, 5:29.
3. Conteh L., Engels T., Molyneux D.H. Socioeconomic aspects of neglected tropical diseases. Lancet 2010, 375:239.
4. Devesa M., Saez A., Leon G., Sirit F., Cosson C., Bermudez H., Liprandi F., Noya O. Restricted isotypic antibody reactivity to hepatitis C virus synthetic peptides in immunocompromised patients. Clin. Diagn. Lab. Immunol 1999, 6:279.
5. Hewer R., Meyer D. Envelope-based HIV vaccine peptides as antigens in HIV-1 immunodiagnostics. Int. J. Biotechnol. 2007, 9:277.
6. Hopp T.P., Woods K.R. Prediction of protein antigenic determinants from amino acid sequences. Proc. Natl. Acad. Sci. 1981, 86:152.
7. Ferrer E., Benitez L., Foster-Cuevas M., Bryce D., Wamae L.W., Onyango-Abuje J.A., Garate T., Harrison L.J.S., Parkhouse R.M.E. Taenia saginata derived synthetic peptides with potential for the diagnosis of bovine cysticercosis. Vet. Parasitol. 2003, 111,:83.
8. Firbas C., Jilma B., Tauber E., Buerger V., Jelovcan S., Lingnau K., Buschle M., Frisch J., Klade C.S. Immunogenicity and safety of a novel therapeutic hepatitis C virus (HCV) peptide vaccine: a randomized, placebo controlled trial for dose optimization in 128 healthy subjects. Vacc 2006, 24:4343.
9. Gomara M.J., Ercilla G., Alsina M.A., Haro I. Assessment of synthetic peptides for hepatitis A diagnosis using biosensor technology. J. Imm. Meth. 2000, 246:13.
10. Gomara M.J., Fernandez L., Perez T., Ercilla G., Haro I. Assessment of synthetic chimeric multiple antigenic peptides for diagnosis of GB virus C infection. Anal. Biochem. 2010, 396:51.
11. Intapan P.M., Tantrawatpan T.C., Maleewong C., Wongkham S., Wongkham C., Nakashima K. Potent epitopes derived from Fasciola gigantica cathepsin L1 in peptide-based immunoassay for the serodiagnosis of human fascioliasis. Diagn. Microbiol. Infect. Dis. 2005, 53:125.
12. Janardhan S., Pandiaraja P., Thirugnanam S., Balamurali M.N., Fernando K., Mody H.C., Desai P.K., Meenakshisundaram S., Kaliraj P. Production, purification and diagnostic application of filarial recombinant protein WbSXP-1 expressed in salt inducible Escherichia coli. J. Ind. Microbiol. Biotech. 2007, 34:675.
13. Lalitha P., Eswaran D., Gnanasekar M., Rao K.V., Narayanan R.B., Scott A., Nutman T., Kaliraj P. Development of antigen detection ELISA for the diagnosis of brugian and bancroftian filariasis using antibodies to recombinant filarial antigens Bm-SXP-1 and Wb-SXP-1. Microbiol. Imm. 2002, 46:327.
14. Lammie P.J., Weil G., Noordin R., Kaliraj P., Steel C., Goodman D., Lakshmikanthan V.B., Ottesen E. Recombinant antigen-based antibody assays for the diagnosis and surveillance of lymphatic filariasis a multicenter trial. Fil. J. 2004, 3:9.
15. McCarthy J. Diagnosis of lymphatic filariasis infection. Lymphatic filariasis 2000, 127. Imper. College Pres.
16. Melrose W.D., Durrheim D.D., Burgess G.W. Update on immunological tests for lymphatic filariasis. Trends Parasitol. 2004, 6:255.
17. Noya O., Patarroyo M.E., Guzman F., Noya B. Immunodiagnosis of parasitic diseases with synthetic peptides. Curr. Protein Pept. Sci. 2003, 4:299.
18. Ottensen E.A. The global programme to eliminate lymphatic filariasis. Trop. Med. Int. Health 2000, 5:591.
19. Pandiaraja P., Murugan V., Hoti S.L., Kaliraj P. Molecular characterization of a truncated antigen (Wb14) of SXP-1 of Wuchereria bancrofti from four endemic regions in India. Exp. Parasitol. 2010, 125:236.
20. Purcell A.W., McCluskey J., Rossjohn J. More than one reason to rethink the use of peptides in vaccine design. Nat 2007, 6:404.
21. Rahmah N., Lim B.H., Anuar A.K., Shenoy R.K., Kumaraswami V., Hakim S.L., Chotechuang P., Kanjanopas K., Ramachandran C.P. A recombinant antigen-based IgG4 ELISA for the specific and sensitive detection of Brugia malayi infection. Trans. Roy. Soc. Trop. Med. Hyg. 2001, 95:280.
22. Rahmah N., Shenoy R.K., Nutman T.B., Weiss N., Gilmour K., Maizels R.M., Yazdanbakhsh M., Sartono E. Multicentre laboratory evaluation of Brugia Rapid dipstick test for detection of brugian filariasis. Trop. Med. Int. Health 2003, 8:895.
23. Rao K.V.N., Eswaran M., Ravi V., Gnanasekhar B., Narayanan R.B., Kaliraj P., Kunthala J., Marson A., Nithyakalyani R., Scott A.L. The Wuchereria bancrofti orthologue of Brugia malayi SXP-1 and the diagnosis of bancroftian filariasis. Mol. Biochem. Parasitol. 2000, 107:71.
24. Sasa M. Human Filariasis: A global survey of Epidemiology and control 1976, University of Tokyo Press, Tokyo, Japan.
25. Weil G., Ramzy R.M.R. Diagnostic tools for filariasis elimination programs. Trends. Parasitol. 2006, 2:78.
26. WHO Global programme for the elimination of lymphatic filariasis 2003, Cds/Cpe/Cee. 39.
27. Zerpa N.C., Wide A., Noda J., Bermudez H., Pabon R., Noya O. Immunogenicity of synthetic peptides derived from Plasmodium falciparum proteins. Exp. Parasitol. 2006, 113:227.